In vitro cytokine production of tnfα and IL-13 correlates with acute liver transplant rejection

Human Immunology

Volumn 62, Issue 11, 2001, Pages 1258-1265

  Warlé, Michiel C ^a   Farhan, Ayar ^b   Metselaar, Herold J ^a   Hop, Wim C J ^a   Van Der Plas, Arnout J ^a   Kap, Marcel ^a   De Rave, Sjoerd ^a   Kwekkeboom, Jaap ^a   Zondervan, Pieter E ^a   IJzermans, Jan N M ^a   Tilanus, Hugo W ^a   Pravica, Vera ^b   Hutchinson, Ian V ^b   Bouma, Gerda J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cytokine; Human; IFN ; IL 10; IL 13; Liver; Rejection; TNF ; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; PREDNISOLONE; PREDNISONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MEGADOSE; FEMALE; GRAFT REJECTION; HUMAN; INDIVIDUALIZATION; LIVER BIOPSY; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REFERENCE VALUE; STATISTICAL ANALYSIS; STEROID THERAPY;

ACUTE DISEASE; ADULT; AGED; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-13; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034768093     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(01)00321-4     Document Type: Article

References (47)

1. Infectious complications in liver transplant recipients on Tacrolimus: Prospective analysis of 88 consecutive liver transplants
2. Post-transplantation de novo tumors in liver allograft recipients
3. Metabolic complications after liver transplantarion: Diabetes, hypercholesterolemia and obesity
4. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation
5. Hepatic allograft rejection: New developments in terminology, diagnosis, prevention, and treatment
6. Intragraft cytokine profile during human liver allograft rejection
7. Cytokine pattern during rejection and infection after liver transplantation-improvements in postoperative monitoring?
8. Correlation of peripheral blood lymphocyte and intragraft cytokine mRNA expression with rejection in orthotopic liver transplantation
9. Intragraft IL-4 mRNA expression is associated with down-regulation of liver graft rejection
10. The expanding universe of T cell subsets: Th1, Th2 and more
11. Cytokine-activated human endothelial monolayers support enhanced neutrophil-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1
12. Raised plasma levels of tumor necrosis factor in heart allograft rejection
13. Analysis of the polymorphism of the tumor necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection
14. Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients
15. Plasma levels of tumor necrosis factor and soluble TNF receptors in kidney transplant recipients
16. The role of tumor necrosis factor in allograft rejection
17. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice
18. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-γ in long surviving mouse heart allografts after brief CD4-monoclonal antibody therapy
19. Properties and functions of interleukin-10
20. IL-10 immunosuppression in transplantation
21. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes
22. High frequency of IL-10-secreting CD4+ graft infiltrating T lymphocytes on promptly rejected kidney allografts
23. Pretransplant CD4+ helper function and interleukin-10 response predict risk of acute kidney graft rejection
24. Secretion of turnout necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease
25. In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-γ gene
26. Genotypic variation in the Transforming Growth Factor-β1 gene
27. An investigation of polymorphism in interleukin-10 gene promoter
28. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to Interferon Alfa
29. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells
30. Atopy and asthma: Genetic variants of IL-4 and IL-13 signaling
31. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection
32. Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts
33. Unbalanced repeated measures models with structured covariance matrices
34. Pre-transplantation Tumor Necrosis Factor-α production predicts acute rejection after liver transplantation
35. The relationship between cytokines in MLC supernatants and acute rejection after renal transplantation
36. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses
37. Local production of cytokines in the human cardiac allograft
38. In vitro cytokine profiles and their relevance to rejection following renal transplantation
39. Cytokine secretion in mixed lymphocyte culture: A prognostic indicator of renal allograft rejection in addition to HLA mismatching
40. Histocompatibilty and liver transplant outcome. Does HLA exert a dualistic effect?
41. Preliminary analysis of HLA matching in pancreas and liver transplantation
42. Relationship between HLA compatibility and first liver allograft survival
43. Influence of HLA matching on liver allograft survival and rejection. "The dualistic effect."
44. Histocompatibility and liver transplantation
45. HLA histocompatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching
46. Evaluating the significance of HLA class II genotype matching in living-related liver transplantation
47. Defining the outcome of immunosuppression withdrawal after liver transplantation